Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes

BACKGROUND: Few studies, if any, have examined cardiovascular outcomes in patients with diabetes and gout. Both diabetes and gout are risk factors for cardiovascular disease. The objective of this study was to examine the effect of allopurinol on the risk of incident acute cardiovascular events in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Jasvinder A., Ramachandaran, Rekha, Yu, Shaohua, Curtis, Jeffrey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348884/
https://www.ncbi.nlm.nih.gov/pubmed/28288564
http://dx.doi.org/10.1186/s12872-017-0513-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348884/
https://www.ncbi.nlm.nih.gov/pubmed/28288564
http://dx.doi.org/10.1186/s12872-017-0513-6

Ejemplares similares